Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator and smooth muscle relaxant, though its exact mechanism of action is not fully understood. It is primarily used for conditions involving impaired peripheral circulation.
## Primary Indications
* Peripheral arterial insufficiency, including intermittent claudication and vasospastic disorders.
* Cerebrovascular insufficiency.
* As an adjunct in the treatment of premature labor (tocolytic).
## Adult Dosing
* **Peripheral arterial insufficiency:** 10 mg to 20 mg orally three to four times daily.
* **Tocolytic:** 10 mg orally every hour for up to 4 hours, followed by 10 mg to 20 mg orally three to four times daily.
## Pediatric Dosing
No established pediatric dosing. Use is generally not recommended in children.
## Dose Adjustments
No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution is advised, and lower doses may be considered.
## Contraindications
* Hypersensitivity to isoxsuprine.
* Use immediately postpartum (except for tocolytic therapy).
* Use in patients with congenital heart defects or arrhythmias.
* Use in patients who have recently experienced a myocardial infarction.
## Adverse Effects
* **Common:** Nausea, vomiting, stomach upset, dizziness, lightheadedness, weakness, flushing, headache, rash.
* **Cardiovascular:** Hypotension, tachycardia, palpitations.
* **Other:** Blurred vision, drowsiness.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Epinephrine:** May antagonize the vasodilator effects of isoxsuprine.
## Monitoring
* Blood pressure and heart rate.
* Symptoms of peripheral circulation (e.g., claudication pain, skin temperature, color).
* Signs of adverse effects.
## Clinical Pearls
* Effectiveness in peripheral arterial insufficiency is controversial and evidence is limited.
* Avoid use in situations where vasodilation could be detrimental.
* Can cause significant hypotension, particularly with higher doses or in susceptible individuals.
* Should be discontinued if symptoms do not improve after a reasonable trial period.
---
***Disclaimer:** This information is intended for clinical use and does not substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare professional for patient-specific guidance. Dosing and indications may vary based on local protocols and individual patient factors.*
